慢性血液透析患者心血管疾病的管理 慢性血液透析患者
Zhen Zhang1,2,3,4, Yaqiong Wang1,2,3,4
1Department of Nephrology, Zhongshan Hospital, Fudan University, 200032 Shanghai, China.
Reviews in cardiovascular medicine
|July 30, 2024
概括
血液透析患者面临高心血管疾病 (CVD) 风险,导致死亡率显著增加. 本综述涵盖了血液透析 (HD) 患者的心血管疾病特征,并探讨了最近的管理进展.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 血液透析 (HD) 是对末期病 (ESKD) 的首要治疗方法.
- 心血管疾病 (CVD) 是HD患者的主要死亡原因,其发病率比一般人群高约20倍.
- 传统和非传统的风险因素加剧了HD患者的心血管疾病进展和结果.
研究的目的:
- 审查血液透析 (HD) 患者心血管疾病 (CVD) 的独特特征.
- 描述最近在HD患者心血管疾病管理方面的进展.
主要方法:
- 文献综述专注于血液透析患者的心血管疾病.
- 综合目前对心血管疾病特征和风险因素的理解.
- 对当代管理策略和治疗进步的概述.
主要成果:
- 患有HD的患者表现出高患病率和心血管疾病的严重程度.
- 加快的心血管疾病进展与传统和非传统的疾病发病风险因素有关.
- 管理方面的进步提供了更好的预后和生活质量.
结论:
- 在疾病重症患者中有效管理心血管疾病需要解决独特的风险因素.
- 持续的研究和临床进展对于改善这一弱势群体的治疗结果至关重要.
- 结合科和心脏病学的综合护理方法是必不可少的.
相关概念视频
Heart Failure Drugs: Diuretics
355
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
355
Dialysis
286
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
286
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.2K
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Hypertension and Regulation of Blood Pressure
2.0K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K


